Elaine O'Hara - 01 Mar 2024 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role: EVP, Chief Strategy Officer
Signature: /s/ Mark J. Casey, Attorney-in-Fact
Issuer symbol: NVAX
Transactions as of: 01 Mar 2024
Net transactions value: +$76,673
Form type: 4
Filing time: 05 Mar 2024, 19:30:14 UTC
Previous filing: 03 Mar 2023
Next filing: 04 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVAX	Common Stock	Options Exercise	$105,644	+19,600		$5.39	19,600	01 Mar 2024	Direct
transaction	NVAX	Common Stock	Tax liability	$28,971	-5,375	-27%	$5.39	14,225	01 Mar 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Restricted Stock Units	Options Exercise	$0	-19,600	-33%	$0.000000	39,200	01 Mar 2024	Common Stock	19,600		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F2	The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.